In today's fast-paced world, many individuals struggle with respiratory issues, whether due to chronic conditions like asthma ...

Objective: To review the basis for the estimated comparative daily dosages of inhaled corticosteroids for children and adults that are presented in the National Heart, Lung, and Blood Institute's ...

Marketed in the past by AstraZeneca as Pulmicort, budesonide is an off-patent inhaled steroid and could be used ... with asthma or chronic obstructive pulmonary disease (COPD) were surprisingly ...

Summary. Exacerbations of COPD are common and can be detrimental to both patient health and health care costs. Corticosteroids are recommended by consensus guidelines for patients during ...

Methods Using gene set variation analysis, we examined the distribution and enrichment scores (ES) of the 3 TACs in the transcriptome of bronchial biopsies from 46 patients who participated in the ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

and COPD. Although the prevalence of eosinophilic bronchitis (EB) is less than in asthma, the causes, mechanisms and treatment of EB in these conditions appears to be similar to asthma where allergen ...

UnitedHealth's pharmacy benefit manager (PBM), after it upped the price of his steroid inhaler from $66 to $539. In their suit, Shanon and William Schmidtknect allege that Optum operates as part ...

Construction dust forms a significant chunk of PM10, particulate matter that is slightly larger in size than dust in general, ...

Patients with bronchiectasis in China have a high disease burden and a low rate of use of evidence-based treatments.

Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...